Another factor that could explain the above discrepancies is that the data reported by Ciavatta et al. [9] included both PR3- and MPO-ANCA patients whereas we have focused solely on PR3-positive (GPA) patients. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.